Tilly's - TLYS Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TLYS shares.
View TLYS analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12 month price objectives for Tilly's' shares. Their TLYS share price forecasts range from $9.00 to $10.00. On average, they anticipate the company's share price to reach $9.50 in the next year. This suggests a possible upside of 34.6% from the stock's current price.
View analysts price targets for TLYS or view top-rated stocks among Wall Street analysts.

Tilly's' stock was trading at $16.11 at the beginning of the year. Since then, TLYS shares have decreased by 56.2% and is now trading at $7.06.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 1st 2022.
View our TLYS earnings forecast.

Tilly's, Inc. (NYSE:TLYS) issued its quarterly earnings results on Thursday, September, 1st. The specialty retailer reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by $0.03. Tilly's had a trailing twelve-month return on equity of 21.23% and a net margin of 5.18%. During the same quarter last year, the business earned $0.66 EPS.

Tilly's announced a dividend on Friday, November 19th. Shareholders of record on Tuesday, December 7th will be given a dividend of $1.00 per share on Wednesday, December 15th. The ex-dividend date is Monday, December 6th.
Read our dividend analysis for TLYS.

Tilly's issued an update on its third quarter 2022 earnings guidance on Thursday, September, 22nd. The company provided earnings per share (EPS) guidance of $0.05-$0.11 for the period, compared to the consensus estimate of $0.21. The company issued revenue guidance of $165.00 million-$170.00 million, compared to the consensus revenue estimate of $172.22 million.

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), KushCo (KSHB), OrganiGram (OGI), Zosano Pharma (ZSAN), DHT (DHT), EnLink Midstream (ENLC) and Washington Prime Group (WPG).

Tilly's trades on the New York Stock Exchange (NYSE) under the ticker symbol "TLYS."

Tilly's' stock is owned by many different institutional and retail investors. Top institutional shareholders include Divisar Capital Management LLC (4.61%), Renaissance Technologies LLC (4.16%), Paradigm Capital Management Inc. NY (3.99%), State Street Corp (2.17%), Emerald Advisers LLC (1.57%) and Emerald Mutual Fund Advisers Trust (1.43%). Insiders that own company stock include Bernard Zeichner, Douglas P Collier, Edmond Thomas, Hezy Shaked, Janet Kerr, Jonathon David Kosoff, Marc Nissan, Michael Henry, Robert Simon Goodwin, Seth R Johnson and Tricia D Smith.
View institutional ownership trends.

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLYS stock can currently be purchased for approximately $7.06.

Tilly's (NYSE:TLYS) has a market capitalization of $212.58 million and generates $775.69 million in revenue each year. The specialty retailer earns $64.25 million in net income (profit) each year or $1.20 on an earnings per share basis.

The company employs 5,700 workers across the globe.

Tilly's' mailing address is 10 WHATNEY, IRVINE CA, 92618. The official website for the company is www.tillys.com. The specialty retailer can be reached via phone at (949) 609-5599, via email at irelations@tillys.com, or via fax at 949-609-5508.